Atopic Eczema

  • Danya Reich
  • Corinna Eleni Psomadakis
  • Bobby Buka
Chapter

Abstract

Atopic eczema is a chronic, relapsing inflammatory skin condition characterized by highly pruritic, xerotic, erythematous papulovesicular rashes that typically appear on the flexor surfaces of the elbows and knees, as well as the face and hands. Atopic eczema is a very common childhood condition, and it is not uncommon in adults. Atopic eczema is associated with other atopic diseases such as asthma and allergic rhinitis. There is no cure for atopic eczema; however, topical corticosteroids can treat acute flare-ups, and frequent use of emollients and moisturizers, as well as avoidance of skin irritance, can help to prevent recurrence.

Keywords

Eczema Atopic dermatitis Atopy Atopic eczema Inflammation Inflammatory Asthma Seasonal allergies Allergic rhinitis Atopic march Hygiene hypothesis Pruritus Pruritic Papule Vesicle Papulovesicular Childhood eczema Filaggrin Xerosis Lichenification Dry skin Emollient Corticosteroid Topical steroid Chronic Relapsing Skin barrier Moisturizer 

References

  1. 1.
    Bieber T. Atopic dermatitis. Ann Dermatol. 2010;22(2):125–37.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131(1):67–73.CrossRefPubMedGoogle Scholar
  3. 3.
    Strachan DP, Aït-Khaled N, Foliaki S, Mallol J, Odhiambo J, Pearce N, Williams HC, ISAAC Phase Three Study Group. Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood. Clin Exp Allergy. 2015;45(1):126–36.CrossRefPubMedGoogle Scholar
  4. 4.
    Madhok V, Futamura M, Thomas KS, Barbarot S. What’s new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 1. Epidemiology, mechanisms of disease and methodological issues. Clin Exp Dermatol. 2015;40(3):238–42.CrossRefPubMedGoogle Scholar
  5. 5.
    Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14):1315–27.CrossRefPubMedGoogle Scholar
  6. 6.
    Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol. 1986;15(3):487–94.CrossRefPubMedGoogle Scholar
  7. 7.
    Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol. 1993;28(5 Pt 1):719–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol. 2010;125(1):16–29.e1–11. quiz 30–1.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Darsow U, Eyerich K, Ring J. Eczema (E), atopic eczema (AE) and atopic dermatitis (AD). Munich: World Allergy Organization; 2014. Available from: http://www.worldallergy.org/professional/allergic_diseases_center/atopiceczema/.
  10. 10.
    Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang MLK. Probiotics for treating eczema. Cochrane Database Syst Rev. 2008;4, CD006135.Google Scholar
  11. 11.
    Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls PI. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol. 2010;162(5):964–73.CrossRefPubMedGoogle Scholar
  12. 12.
    Madhok V, Futamura M, Thomas KS, Barbarot S. What’s new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention. Clin Exp Dermatol. 2015;40(4):349–54. quiz 354–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski JC, Taïeb A, Werfel T, Wollenberg A, Darsow U, European Dermatology Forum (EDF); European Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global Allergy and Asthma European Network (GA2LEN). Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–60.CrossRefPubMedGoogle Scholar
  14. 14.
    Williams HC. Atopic dermatitis. N Engl J Med. 2005;352(22):2314–24.CrossRefPubMedGoogle Scholar
  15. 15.
    Cuello-Garcia CA, Brożek JL, Fiocchi A, Pawankar R, Yepes-Nuñez JJ, Terracciano L, Gandhi S, Agarwal A, Zhang Y, Schünemann HJ. Probiotics for the prevention of allergy: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2015;136(4):952–61.CrossRefPubMedGoogle Scholar
  16. 16.
    Zuccotti G, Meneghin F, Aceti A, Barone G, Callegari ML, Di Mauro A, Fantini MP, Gori D, Indrio F, Maggio L, Morelli L, Corvaglia L, Italian Society of Neonatology. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 2015;70(11):1356–71.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Open Access This chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  • Danya Reich
    • 1
  • Corinna Eleni Psomadakis
    • 2
  • Bobby Buka
    • 3
  1. 1.Department of Family MedicineMount Sinai School of Medicine Attending Mount Sinai Doctors/Beth Israel Medical Group-WilliamsburgBrooklynUSA
  2. 2.School of Medicine Imperial College LondonLondonUK
  3. 3.Department of DermatologyMount Sinai School of MedicineNew YorkUSA

Personalised recommendations